Treating vascular risk factors and maintaining vascular health: Is this the way towards successful cognitive ageing and preventing cognitive decline?
暂无分享,去创建一个
H. Feldman | P. McCracken | K. Alagiakrishnan | K Alagiakrishnan | P McCracken | H Feldman | H. Feldman | Howard Feldman
[1] Kenneth Rockwood,et al. Use of lipid-lowering agents, indication bias, and the risk of dementia in community-dwelling elderly people. , 2002, Archives of neurology.
[2] H Matsuda,et al. Donepezil hydrochloride preserves regional cerebral blood flow in patients with Alzheimer's disease. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[3] J. Barrio,et al. P-79: The effect of blood pressure control on cognitive function (the focus study) , 2001 .
[4] B. Winblad,et al. Occurrence and progression of dementia in a community population aged 75 years and older: relationship of antihypertensive medication use. , 1999, Archives of neurology.
[5] C. Schweiger. [Statins and the risk of dementia]. , 2001, Italian heart journal. Supplement : official journal of the Italian Federation of Cardiology.
[6] M. Béné,et al. CSF-folate levels are decreased in late-onset AD patients , 2001, Journal of Neural Transmission.
[7] Annalena Venneri,et al. Cerebral blood flow and cognitive responses to rivastigmine treatment in Alzheimer's disease , 2002, Neuroreport.
[8] J. Shepherd,et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial , 2003 .
[9] J. Benito-León,et al. Serum levels of β‐carotene, α‐carotene and vitamin A in patients with Alzheimer's disease , 1999, European journal of neurology.
[10] E. Barrett-Connor,et al. Serum lipoprotein levels, statin use, and cognitive function in older women. , 2002, Archives of neurology.
[11] D. Fuchs,et al. Homocysteine and B vitamins in dementia. , 2001, The American journal of clinical nutrition.
[12] S. Mayor. Regulatory authorities review use of galantamine in mild cognitive impairment , 2005, BMJ : British Medical Journal.
[13] B. Winblad,et al. An active and socially integrated lifestyle in late life might protect against dementia , 2004, The Lancet Neurology.
[14] R. Brookmeyer,et al. Survival following a diagnosis of Alzheimer disease. , 2002, Archives of neurology.
[15] R. L. Rogers,et al. Randomized Clinical Trial of Daily Aspirin Therapy in Multi‐Infarct Dementia , 1989, Journal of the American Geriatrics Society.
[16] R Brookmeyer,et al. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. , 1998, American journal of public health.
[17] A. Hofman,et al. The Study on COgnition and Prognosis in the Elderly (SCOPE); outcomes in patients not receiving add-on therapy after randomization , 2004, Journal of hypertension.
[18] P Woodbury,et al. A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study. , 1997, The New England journal of medicine.
[19] Laura Fratiglioni,et al. Late-life engagement in social and leisure activities is associated with a decreased risk of dementia: a longitudinal study from the Kungsholmen project. , 2002, American journal of epidemiology.
[20] G. Reaven,et al. Verbal Learning and/or Memory Improves with Glycemic Control in Older Subjects with Non‐Insulin‐Dependent Diabetes Mellitus , 1993, Journal of the American Geriatrics Society.
[21] S. Cummings,et al. Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial. , 2005, The American journal of psychiatry.
[22] J. Tuomilehto,et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial , 1998, The Lancet.
[23] B. Singer,et al. Price of adaptation--allostatic load and its health consequences. MacArthur studies of successful aging. , 1997, Archives of internal medicine.
[24] M. Mattson,et al. Folic Acid Deficiency and Homocysteine Impair DNA Repair in Hippocampal Neurons and Sensitize Them to Amyloid Toxicity in Experimental Models of Alzheimer's Disease , 2002, The Journal of Neuroscience.
[25] Jaakko Tuomilehto,et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. , 2002 .
[26] G. Celesia,et al. Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. , 2000, Archives of neurology.
[27] Qiang Xu,et al. Secretion of apolipoprotein E by brain glia requires protein prenylation and is suppressed by statins , 2002, Brain Research.
[28] M. Hennerici,et al. Simvastatin strongly reduces levels of Alzheimer's disease beta -amyloid peptides Abeta 42 and Abeta 40 in vitro and in vivo. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Lindsay,et al. Physical activity and risk of cognitive impairment and dementia in elderly persons. , 2001, Archives of neurology.
[30] Jan A Staessen,et al. The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. , 2002, Archives of internal medicine.
[31] C. Bergmann,et al. Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[32] K. Hensley,et al. Oxidative stress in brain aging Implications for therapeutics of neurodegenerative diseases , 2002, Neurobiology of Aging.
[33] G. Vega,et al. Reduction in levels of 24S-hydroxycholesterol by statin treatment in patients with Alzheimer disease. , 2003, Archives of neurology.
[34] B. Winblad,et al. Statins in the Prevention and Treatment of Alzheimer Disease , 2002, Alzheimer disease and associated disorders.
[35] D. Fuchs,et al. Hyperhomocysteinemia in dementia , 2000, Neurobiology of Aging.
[36] Jiankang Liu,et al. Stress, Aging, and Brain Oxidative Damage , 1999, Neurochemical Research.
[37] Paolo Vitali,et al. Hippocampal perfusion in mild Alzheimer's disease , 2000, Psychiatry Research: Neuroimaging.
[38] N. Cohen,et al. Aerobic fitness reduces brain tissue loss in aging humans. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.
[39] S. Kalmijn. Fatty acid intake and the risk of dementia and cognitive decline: a review of clinical and epidemiological studies. , 2000, The journal of nutrition, health & aging.
[40] H. Tuokko,et al. The effect of improved glycemic control on cognitive functions in the elderly patient with diabetes. , 1993, Journal of gerontology.
[41] D. Blacker. Mild cognitive impairment--no benefit from vitamin E, little from donepezil. , 2005, The New England journal of medicine.
[42] Yvette I. Sheline,et al. Depression Duration But Not Age Predicts Hippocampal Volume Loss in Medically Healthy Women with Recurrent Major Depression , 1999, The Journal of Neuroscience.
[43] Denis A. Evans,et al. Vitamin E and cognitive decline in older persons. , 2002, Archives of neurology.
[45] M. Grundman,et al. Antioxidant strategies for Alzheimer's disease , 2002, Proceedings of the Nutrition Society.
[46] A. Hofman,et al. Dietary fat intake and the risk of incident dementia in the Rotterdam study , 1997, Annals of neurology.
[47] J. Ramsdell,et al. Nutritional status of free-living Alzheimer's patients. , 1989, The American journal of the medical sciences.
[48] H. Dodge,et al. Use of Lipid‐Lowering Drugs in Older Adults With and Without Dementia: A Community‐Based Epidemiological Study , 2002, Journal of the American Geriatrics Society.
[49] E. Feskens,et al. Polyunsaturated fatty acids, antioxidants, and cognitive function in very old men. , 1997, American journal of epidemiology.
[50] J. Dichgans,et al. Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26‐week randomized, placebo‐controlled, double‐blind trial , 2002, Annals of neurology.
[51] V. Hirth,et al. The impact of the use of statins on the prevalence of dementia and the progression of cognitive impairment. , 2002, The journals of gerontology. Series A, Biological sciences and medical sciences.
[52] P. Macfarlane,et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial , 2002, The Lancet.
[53] K Yaffe,et al. A prospective study of physical activity and cognitive decline in elderly women: women who walk. , 2001, Archives of internal medicine.
[54] B. Vellas,et al. Low plasma vitamin C in Alzheimer patients despite an adequate diet , 1998, International journal of geriatric psychiatry.
[55] B. Winblad,et al. Vitamin B12 and folate in relation to the development of Alzheimer’s disease , 2001, Neurology.
[56] D. Bennett,et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. , 2005, The New England journal of medicine.
[57] Robert B. Wallace,et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. , 2003 .